ATE426024T1 - C-c chemokin rezeptor 3: ckr-3 oder eos-l2 - Google Patents
C-c chemokin rezeptor 3: ckr-3 oder eos-l2Info
- Publication number
- ATE426024T1 ATE426024T1 AT96907010T AT96907010T ATE426024T1 AT E426024 T1 ATE426024 T1 AT E426024T1 AT 96907010 T AT96907010 T AT 96907010T AT 96907010 T AT96907010 T AT 96907010T AT E426024 T1 ATE426024 T1 AT E426024T1
- Authority
- AT
- Austria
- Prior art keywords
- ckr
- eos
- recombinant
- chemokine receptor
- polypeptides
- Prior art date
Links
- 108020003175 receptors Proteins 0.000 title abstract 4
- 102000005962 receptors Human genes 0.000 title abstract 4
- 102000001902 CC Chemokines Human genes 0.000 title abstract 2
- 108010040471 CC Chemokines Proteins 0.000 title abstract 2
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 title 1
- 101000980744 Homo sapiens C-C chemokine receptor type 3 Proteins 0.000 title 1
- 101150004010 CXCR3 gene Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/375,199 US6806061B1 (en) | 1995-01-19 | 1995-01-19 | G protein-coupled receptor gene and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE426024T1 true ATE426024T1 (de) | 2009-04-15 |
Family
ID=23479910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96907010T ATE426024T1 (de) | 1995-01-19 | 1996-01-19 | C-c chemokin rezeptor 3: ckr-3 oder eos-l2 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6806061B1 (de) |
EP (1) | EP0828828B1 (de) |
JP (1) | JPH10512753A (de) |
KR (1) | KR19980701570A (de) |
AT (1) | ATE426024T1 (de) |
AU (1) | AU688206B2 (de) |
CA (1) | CA2207086A1 (de) |
DE (1) | DE69637874D1 (de) |
ES (1) | ES2324502T3 (de) |
WO (1) | WO1996022371A2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6806061B1 (en) * | 1995-01-19 | 2004-10-19 | Children's Medical Center Corporation | G protein-coupled receptor gene and methods of use therefor |
US6537764B1 (en) | 1995-01-19 | 2003-03-25 | Children's Medical Center Corporation | Method of identifying inhibitors of C—C chemokine receptor 3 |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6512103B1 (en) | 1995-12-08 | 2003-01-28 | Schering Corporation | Mammalian chemokine reagents |
US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
CA2252850A1 (en) * | 1996-04-26 | 1997-11-06 | Merck & Co., Inc. | Eosinophil eotaxin receptor |
US6271347B1 (en) | 1996-04-26 | 2001-08-07 | Merck & Co., Inc. | Eosinophil eotaxin receptor |
ES2288305T3 (es) * | 1996-09-10 | 2008-01-01 | Theodor-Kocher Institute | Receptor de quimiocinas cxcr3, anticuerpos, acidos nucleicos y metodos de uso. |
AU6132698A (en) * | 1997-01-23 | 1998-08-18 | Schering Corporation | Mammalian chemokines; receptors; reagents; uses |
US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6204024B1 (en) | 1997-09-12 | 2001-03-20 | Akzo Nobel N.V. | CCR5 RNA transcription based amplification assay |
US6110695A (en) * | 1997-12-02 | 2000-08-29 | The Regents Of The University Of California | Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1 |
CA2235420A1 (en) | 1998-06-17 | 1999-12-17 | Paolo Renzi | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6670149B1 (en) | 1999-03-01 | 2003-12-30 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel nucleic acids and uses therefor |
US6664373B1 (en) | 1999-03-01 | 2003-12-16 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel polypeptides and uses therefor |
US6358697B2 (en) | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
GB0013345D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Modified receptor and assay |
AU2001286519A1 (en) | 2000-08-15 | 2002-02-25 | Millennium Pharmaceuticals, Inc. | Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10 |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
CA2456928A1 (en) * | 2001-08-10 | 2003-02-20 | Topigen Pharmaceutique Inc. | Cellular virus receptors and methods of use |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
WO2005105841A2 (en) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
WO2005106492A2 (en) * | 2004-04-30 | 2005-11-10 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
CA2584457C (en) * | 2004-10-29 | 2012-10-23 | Topigen Pharmaceuticals Inc. | Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
US8008092B2 (en) | 2007-10-09 | 2011-08-30 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
WO2010138591A1 (en) | 2009-05-26 | 2010-12-02 | University Of Kentucky Research Foundation | Ccr3 and its ligands are therapeutic and diagnostic targets for neovascular age-related macular degeneration |
DK3050574T3 (da) | 2015-01-28 | 2020-01-20 | Univ Bordeaux | Anvendelse af plerixafor til behandling og/eller forebyggelse af akutte forværringer af kronisk obstruktiv lungesygdom |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5284746A (en) | 1990-02-08 | 1994-02-08 | Zymogenetics, Inc. | Methods of producing hybrid G protein-coupled receptors |
US5462856A (en) | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
US5453491A (en) | 1990-09-11 | 1995-09-26 | Kiyoshi Takatsu | Murine interleukin-5 receptor |
US5543503A (en) | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
US5668006A (en) | 1992-07-17 | 1997-09-16 | American Cyanamid Company | Somatostatin receptors |
US5508384A (en) | 1992-09-10 | 1996-04-16 | New York University | Polypeptide derived from a popamine receptor, and compositions and methods thereof |
DE69333885T2 (de) | 1992-11-10 | 2006-09-14 | Genentech, Inc., South San Francisco | C-c ckr-1, ein c-c chemokin rezeptor |
JPH07503145A (ja) | 1992-11-17 | 1995-04-06 | イコス コーポレイション | 新規の7−トランスメンブランレセプター |
US5652133A (en) | 1993-01-28 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor |
US5514555A (en) | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
DE4332256C1 (de) | 1993-09-22 | 1995-03-09 | Lipp Martin Dr Dr Habil | Monoklonale Antikörper gegen Leukozyten-spezifische G-Protein-gekoppelte Rezeptoren |
US6806061B1 (en) * | 1995-01-19 | 2004-10-19 | Children's Medical Center Corporation | G protein-coupled receptor gene and methods of use therefor |
US6512103B1 (en) | 1995-12-08 | 2003-01-28 | Schering Corporation | Mammalian chemokine reagents |
US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
-
1995
- 1995-01-19 US US08/375,199 patent/US6806061B1/en not_active Expired - Fee Related
-
1996
- 1996-01-19 EP EP96907010A patent/EP0828828B1/de not_active Revoked
- 1996-01-19 ES ES96907010T patent/ES2324502T3/es not_active Expired - Lifetime
- 1996-01-19 AT AT96907010T patent/ATE426024T1/de not_active IP Right Cessation
- 1996-01-19 AU AU50202/96A patent/AU688206B2/en not_active Ceased
- 1996-01-19 CA CA002207086A patent/CA2207086A1/en not_active Abandoned
- 1996-01-19 JP JP8522363A patent/JPH10512753A/ja not_active Ceased
- 1996-01-19 DE DE69637874T patent/DE69637874D1/de not_active Expired - Lifetime
- 1996-01-19 WO PCT/US1996/000608 patent/WO1996022371A2/en not_active Application Discontinuation
-
1997
- 1997-07-18 KR KR19970704962A patent/KR19980701570A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2207086A1 (en) | 1996-07-25 |
EP0828828B1 (de) | 2009-03-18 |
WO1996022371A2 (en) | 1996-07-25 |
JPH10512753A (ja) | 1998-12-08 |
US6806061B1 (en) | 2004-10-19 |
ES2324502T3 (es) | 2009-08-07 |
WO1996022371A3 (en) | 1996-10-17 |
EP0828828A2 (de) | 1998-03-18 |
AU688206B2 (en) | 1998-03-05 |
AU5020296A (en) | 1996-08-07 |
KR19980701570A (de) | 1998-05-15 |
DE69637874D1 (de) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637874D1 (de) | C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 | |
LU90591I2 (fr) | Enbrel-etanercept | |
ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
ES2147553T3 (es) | Vectores virales recombinantes para la expresion en unas celulas musculares. | |
BR9813608A (pt) | Polipeptìdeo isolado, sequências de ácido nucleico isolado e mutante, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, processos para produzir uma sequência de ácido nucleico mutante, para produzir um polipeptìdeo, para produzir um mutante de uma célula originária e para produzir uma proteìna, e, célula mutante | |
PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
DE69738514D1 (de) | Verbesserte expressionsvektoren | |
ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
EP1717315A3 (de) | Osteoprotegerin bindende Proteine und Rezeptoren | |
WO1995009872B1 (en) | Dna encoding prostaglandin receptor ip | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
AR016436A1 (es) | Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades | |
KR940021579A (ko) | 골(骨)-관련 전사 조절인자형 단백질 및 이의 제조방법 | |
AUPN154295A0 (en) | Nucleic acid molecule encoding a protein with avian gamma-interferon activity | |
CA2032167A1 (en) | Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene | |
Sarvas et al. | A precursor form of the penicillinase from Bacillus licheniformis | |
ATE302214T1 (de) | Enamel-matrix bezogene polypeptide | |
EP0811685A3 (de) | Menschliche Rezeptoren für den von Blutplättchen abstammenden Wachstumsfaktor | |
DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
WO1997008317A3 (en) | Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |